Replies to post #369 on SCYNEXIS (SCYX)

[$Pistol Pete$]

$SCYX SCYNEXIS, Inc. to Present at the Ladenburg Thalmann Healthcare Conference
GlobeNewswire - Tue Sep 20, 8:05AM CDT
Drug development company SCYNEXIS, Inc. (NASDAQ:SCYX) today announced that the Company will present at the Ladenburg Thalmann Healthcare Conference at the Sofitel New York Hotel on Tuesday, September 27, 2016 at 3:00 p.m. ET.

A live webcast will be available on the investors section of the Company's website: www.SCYNEXIS.com. A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.

About SCYNEXIS

SCYNEXIS is a pharmaceutical company committed to the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. We are developing our lead product candidate, SCY-078, as an oral and IV drug for the treatment of serious and life-threatening invasive fungal infections. For more information, visit www.SCYNEXIS.com.

CONTACT:

Media Relations
Blair Atkinson
MacDougall Biomedical Communications
Tel: [phone]
[e-mail]

Investor Relations
Susan Kim
Argot Partners
Tel: [phone]
[e-mail]
https://resource.globenewswire.com/Resource/Download/09db4950-cb33-4eb6-aa0f-ef73618cf50b?size=1

<img src="http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzY0NzAzODc="; alt="" width="1" height="1"/>